|
|
||||||||
1 Programme in Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8; and 2 Department of Woman and Child Health, Pediatric Unit, Astrid Lindgren Children's Hospital, Karolinska Hospital, S-171 76 Stockholm, Sweden
The activity of
the
Na+-K+-pump
is intricately linked to the maintenance of vascular tone. Here we
demonstrate that insulin-like growth factor I (IGF-I) increases
Na+-K+-pump
activity in the vascular smooth muscle cell (VSMC) clone A7r5 in a
time- and dose-dependent manner. This stimulatory effect of IGF-I was
prevented by the tyrosine kinase inhibitor genistein (5 µM) and by
the specific phosphatidylinositol 3-kinase (PI3K) inhibitors wortmannin
(100 nM) and LY-294002 (25 µM). IGF-I activated a
wortmannin-sensitive PI3K and its purported effector, the atypical protein kinase C (PKC)-
. Stimulation of PKC-
was
prevented by the generic PKC inhibitor GF109203x (bisindolylmaleimide,
10 µM). Downregulation of diacylglycerol-sensitive (conventional and
novel) PKCs by 24-h pretreatment with 1 µM phorbol 12-myristate
13-acetate had no effect on IGF-I-stimulated
Na+-K+-pump
activity. Similarly, inhibition of only conventional and novel PKCs
with GF109203x (1 µM) had no effect on IGF-I-stimulated Na+-K+-pump
activity. In contrast, a concentration of GF109203x (10 µM) that also
inhibits the atypical PKCs abolished
Na+-K+-pump
stimulation by IGF-I. Neither the
Na+-K+-2Cl
cotransporter inhibitor bumetanide (100 µM) nor the
Na+/H+
exchanger inhibitor HOE-694 (5 µM) affected the
Na+-K+-pump
stimulation by IGF-I, suggesting that a rise in intracellular Na+ concentration is not necessary
for increased
Na+-K+-pump
activity. These results suggest that IGF-I directly stimulates the
Na+-K+
pump via a signaling pathway involving PI3K and atypical PKC (
).
sodium-potassium adenosine 5'-triphosphatase; tyrosine kinase; vascular resistance
This article has been cited by other articles:
![]() |
J. R. Sowers Insulin resistance and hypertension Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1597 - H1602. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Buhagiar, P. S. Hansen, B. Y. Kong, R. J. Clarke, C. Fernandes, and H. H. Rasmussen Dietary cholesterol alters Na+/K+ selectivity at intracellular Na+/K+ pump sites in cardiac myocytes Am J Physiol Cell Physiol, February 1, 2004; 286(2): C398 - C405. [Abstract] [Full Text] |
||||
![]() |
G. Sweeney, W. Niu, V. A. Canfield, R. Levenson, and A. Klip Insulin increases plasma membrane content and reduces phosphorylation of Na+-K+ pump alpha 1-subunit in HEK-293 cells Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1797 - C1803. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Therien and R. Blostein Mechanisms of sodium pump regulation Am J Physiol Cell Physiol, September 1, 2000; 279(3): C541 - C566. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Hansen, K. A. Buhagiar, D. F. Gray, and H. H. Rasmussen Voltage-dependent stimulation of the Na+-K+ pump by insulin in rabbit cardiac myocytes Am J Physiol Cell Physiol, March 1, 2000; 278(3): C546 - C553. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Feschenko, E. Stevenson, and K. J. Sweadner Interaction of Protein Kinase C and cAMP-dependent Pathways in the Phosphorylation of the Na,K-ATPase J. Biol. Chem., October 27, 2000; 275(44): 34693 - 34700. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |